Equity | US Equity

Invesco NASDAQ Future Gen 200 ETF

Ticker: QQQS
How to invest How to invest

Product Details

The Invesco NASDAQ Future Gen 200 ETF (Fund) is based on the Nasdaq Innovators Completion Cap Index (Index). The Fund will invest at least 90% of its total assets in the securities that comprise the Index. The Index consists of 200 small-cap companies with the most valuable patent portfolios relative to their total market value as deemed by Nasdaq. The eligible universe consists of the companies within the Nasdaq Composite Index, excluding those companies included in the Nasdaq-100 Index and Nasdaq Next Generation 100 Index. Each constituent within the Index is equally weighted. The Fund and Index are rebalanced quarterly and reconstituted semi-annually.

as of 01/31/2024 12/31/2023

Performance

Index History (%) YTD 1Yr 3Yr 5Yr 10Yr Since Inception
Nasdaq Innovators Completion Cap Total Return Index -3.64 -17.21 N/A N/A N/A 0.57
NASDAQ Composite Total Return Index (USD) 1.04 31.99 5.90 16.80 15.11 32.40
Russell 2000 Total Return Index (USD) -3.89 2.40 -0.76 6.80 7.03 11.32
Fund History (%)
Fund NAV -3.62 -17.48 N/A N/A N/A 0.49
After Tax Held -3.62 -17.64 N/A N/A N/A 0.32
After Tax Sold -2.14 -10.28 N/A N/A N/A 0.35
Fund Market Price -3.65 -17.42 N/A N/A N/A 0.46
Index History (%) YTD 1Yr 3Yr 5Yr 10Yr Since Inception
Nasdaq Innovators Completion Cap Total Return Index -2.12 -2.12 N/A N/A N/A 3.73
NASDAQ Composite Total Return Index (USD) 44.64 44.64 6.04 18.75 14.80 33.83
Russell 2000 Total Return Index (USD) 16.93 16.93 2.22 9.97 7.16 15.87
Fund History (%)
Fund NAV -2.12 -2.12 N/A N/A N/A 3.61
After Tax Held -2.39 -2.39 N/A N/A N/A 3.37
After Tax Sold -1.25 -1.25 N/A N/A N/A 2.66
Fund Market Price -2.05 -2.05 N/A N/A N/A 3.61

This is a new Fund and has no full-year Fund performance to report as of most recent quarter end.

Market returns are based on the midpoint of the bid/ask spread at 4 p.m. ET and do not represent the returns an investor would receive if shares were traded at other times. Performance data quoted represents past performance, which is not a guarantee of future results. Investment returns and principal value will fluctuate, and shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than performance data quoted. After-tax returns reflect the highest federal income tax rate but exclude state and local taxes. Fund performance reflects applicable fee waivers, absent which, performance data quoted would have been lower. After Tax Held and After Tax Sold are based on NAV. Returns less than one year are cumulative.

An investor cannot invest directly in an index. The results assume that no cash was added to or assets withdrawn from the Index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.

as of 12/31/2023

Growth of $10,000

Data beginning Fund inception and ending 12/31/2023. Fund performance shown at NAV.

An investor cannot invest directly in an index. The results assume that no cash was added to or assets withdrawn from the Index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.

as of 02/21/2024

Market Cap & Style Allocations

Large-Cap Value -
Large-Cap Blend -
Large-Cap Growth 0.54%
Mid-Cap Value -
Mid-Cap Blend 1.79%
Mid-Cap Growth -
Small-Cap Value 32.99%
Small-Cap Blend 38.79%
Small-Cap Growth 25.88%

as of 02/23/2024 Top Holdings

Fund Holdings subject to change

Ticker Company % of Fund
OCUL Ocular Therapeutix Inc 1.63
ALT Altimmune Inc 1.21
FATE Fate Therapeutics Inc 1.15
IOVA Iovance Biotherapeutics Inc 1.07
LXRX Lexicon Pharmaceuticals Inc 0.99
MRSN Mersana Therapeutics Inc 0.95
MGNX MacroGenics Inc 0.91
KOD Kodiak Sciences Inc 0.90
ALPN Alpine Immune Sciences Inc 0.90
ARVN Arvinas Inc 0.89

Distributions | Hide View All | Distribution Information

Ex-Date Record Date Pay Date $/
Share
Ordinary Income Short Term Gains Long Term Gains Return of Capital Liquidation Distribution
12/18/2023 12/19/2023 12/22/2023 0.03706 0.03706 - - - -
09/18/2023 09/19/2023 09/22/2023 0.02839 0.02839 - - - -
06/20/2023 06/21/2023 06/23/2023 0.03563 0.03563 - - - -
03/20/2023 03/21/2023 03/24/2023 0.07699 0.07699 - - - -
12/19/2022 12/20/2022 12/23/2022 0.01075 0.01075 - - - -

Frequency Distribution of Discounts & Premiums

    Bid/Ask MidPoint Above NAV
Quarter
Ending
Days 0.00-
0.25%
0.26-
0.50%
0.51-
0.99%
1.00-
1.49%
1.50-
1.99%
≥2.00%
12/31/2023 63 32 1 0 0 0 0
09/30/2023 63 51 0 0 0 0 0
06/30/2023 62 33 0 0 0 0 0
03/31/2023 62 34 0 0 0 0 0
Year Ended 2023 250 150 1 0 0 0 0
    Bid/Ask Midpoint Below NAV
Quarter
Ending
Days 0.00-
0.25%
0.26-
0.50%
0.51-
0.99%
1.00-
1.49%
1.50-
1.99%
≥2.00%
12/31/2023 63 30 0 0 0 0 0
09/30/2023 63 12 0 0 0 0 0
06/30/2023 62 29 0 0 0 0 0
03/31/2023 62 27 1 0 0 0 0
Year Ended 2023 250 98 1 0 0 0 0

Fund Inception : 10/13/2022

Shareholders may pay more than net asset value when they buy Fund shares and receive less than net asset value when they sell those shares, because shares are bought and sold at current market prices. Performance data quoted represents past performance, which is not a guarantee of future results.

Premiums/Discounts

Shareholders may pay more than net asset value when they buy Fund shares and receive less than net asset value when they sell those shares, because shares are bought and sold at current market prices. Performance data quoted represents past performance, which is not a guarantee of future results.

 Risk & Other Information

Typically, security classifications used in calculating allocation tables are as of the last trading day of the previous month.

There are risks involved with investing in ETFs, including possible loss of money. Shares are not actively managed and are subject to risks similar to those of stocks, including those regarding short selling and margin maintenance requirements. Ordinary brokerage commissions apply. The Fund’s return may not match the return of the Underlying Index. The Fund is subject to certain other risks. Please see the current prospectus for more information regarding the risk associated with an investment in the Fund.

The Fund is non-diversified and may experience greater volatility than a more diversified investment.

The risks of investing in securities of foreign issuers can include fluctuations in foreign currencies, political and economic instability, and foreign taxation issues.

Investments focused in a particular sector, such as information technology and health care, are subject to greater risk, and are more greatly impacted by market volatility, than more diversified investments.

Stocks of small and mid-sized companies tend to be more vulnerable to adverse developments, may be more volatile, and may be illiquid or restricted as to resale.

The Fund’s Underlying Index (Index) is composed of companies with valuable portfolios of patents. The Index Provider relies on an independent data provider to ascertain the potential value of an issuer’s patents and related intangible assets (i.e., intellectual property and research & development activities) for inclusion in the Index. The Fund’s performance may suffer if the data provider’s does not correctly value an issuer’s patents or if the companies included in the Index ultimately do not benefit from holding such patents. There is no guarantee that the Index will be composed of companies with the most valuable patents.

The NASDAQ Composite Index measures all NASDAQ domestic and international-based common stocks listed on The Nasdaq Stock Market. The Russell 2000® Index measures the performance of the small-cap segment of the US equity universe. The Russell 2000® Index is a trademark/service mark of the Frank Russell Co. Russell® is a trademark of the Frank Russell Co. The Nasdaq-100 Index comprises the 100 largest non-financial companies traded on the Nasdaq. The Nasdaq Next Generation 100 Index® is designed to measure the performance of the next generation of Nasdaq-listed non-financial companies; that is, the largest 100 companies outside of the Nasdaq-100 Index®.

The Invesco NASDAQ Future Gen 200 ETF is not sponsored, endorsed, sold or promoted by the NASDAQ OMX Group, Inc. or its affiliates (NASDAQ OMX, with its affiliates, are referred to as the "Corporations"). The Corporations have no liability in connection with the administration, marketing or trading of the Invesco NASDAQ Future Gen 200 ETF. "NASDAQ®" is a registered trademark and is used under license.